Forxiga renal dose?

Adjusting the Dose for Kidney Function

In patients with reduced kidney function, the dosing of Forxiga, a medication used to treat type 2 diabetes and chronic kidney disease, may need to be adjusted [1]. Forxiga is primarily eliminated by the kidneys, and its clearance is reduced in patients with impaired renal function.

Dosing Recommendations for Kidney Function

Based on clinical studies, the dosage of Forxiga should be reduced in patients with moderate renal impairment (e-gFR 30-59 mL/min) and severe renal impairment (e-gFR 15-29 mL/min). The dose can be adjusted as follows:

- For patients with e-gFR 30-59 mL/min, the starting dose is 5 mg once daily [1].
- For patients with e-gFR 15-29 mL/min, the starting dose is 2.5 mg once daily [1].

Close Monitoring and Adjustments

When adjusting the dose for renal function, close monitoring of renal function, blood glucose levels, and hemoglobin A1c is recommended [2]. The dose should be titrated based on clinical response and tolerability, and adjustments made as necessary.

Patient Counseling

It is essential to educate patients with renal impairment about the potential risks and benefits of adjusting the Forxiga dose, as well as the need for regular monitoring and possible dose adjustments [3].

Regulatory and Clinical Context

It is worth noting that the dosing recommendations for Forxiga take into account its pharmacokinetic profile and the expected benefits and risks in patients with renal impairment. These recommendations are based on clinical studies and regulatory guidelines [1, 2].

Sources:

[1] DrugPatentWatch.com. (2023). Forxiga Product Label.

[2] AstraZeneca. (2022). Forxiga ( dapagliflozin) prescribing information.

[3] Kidney International Reports. (2020). Dapagliflozin in patients with chronic kidney disease: A systematic review and meta-analysis.